Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors type 1 and 2 in human and rhesus monkey fetal membranes

Placenta

Volumn 19, Issue 2-3, 1998, Pages 171-180

  Liu, Y X ^a   Hu, Z Y ^a   Liu, K ^b   Byrne, S ^c   Zou, R J ^d   Ny, T ^b   D'Lacey, C ^c   Ockleford, C D ^c  

^a INSTITUTE OF ZOOLOGY   (China)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AMNION; AMNION CELL; AMNION FLUID; ANIMAL TISSUE; ARTICLE; CHORION; CONTROLLED STUDY; DECIDUA; EXTRACELLULAR MATRIX; FEMALE; FETUS DEVELOPMENT; FETUS GROWTH; FETUS MEMBRANE; FIBRINOLYSIS; FIBROBLAST; IMMUNOFLUORESCENCE MICROSCOPY; IN SITU HYBRIDIZATION; LABOR; MATURATION; MEMBRANE RUPTURE; MESSENGER RNA SYNTHESIS; NONHUMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHESUS MONKEY; TROPHOBLAST;

EID: 0031913288     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(98)90006-6     Document Type: Article

References (71)

1. Alger LS & Pupkin MJ (1986) Etiology of preterm premature rupture of the membranes. Clin Obstet Gynecol, 29, 758-770.
2. Artal R, Sokol R, Newman M, Burstein A & Stojkov J (1976) The mechanical properties of prematurely and nonprematurely ruptured membranes. Am J Obstet Gynaecol, 125, 655-671.
3. Åstedt B, Hagerstrand I & Lecander I (1986) Cellular localization in placenta of placental type plasminogen activator inhibitor. Thromb Haemost, 53, 122-125.
4. Bourne GL (1962) The Human Amnion and Chorion. London: Lloyds.
5. Bradbury FM & Ockleford CD (1990) A confocal and conventional epifluorescence microscope study of intermediate filaments in chorionic villi. J Anat, 169, 173-187.
6. Burgos H, Hsi BL, Yeh CJ & Faulk WP (1982) Plasminogen binding by human amniochorion. A possible factor in premature rupture of membrane. Am J Obstet Gynecol, 143, 958-963.
7. Chomczynski P & Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156-159.
8. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Neilsen LS & Skrivers L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res, 44, 139-266.
9. Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP & Porreco R (1995) Elevated protease activators in human amnion and chorion correlate with premature rupture of membranes. Am J Obstet Gynecol, 173, 1506-1512.
10. Estellés A, Gilabert J, Aznar J, Loskutoff DJ & Schleef RR (1989) Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood, 74, 1332-1338.
11. Estellés A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, España F, Loskutoff DJ & Schleef RR (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood, 84, 143-150.
12. Fazleabas AT, Everly SL & Lottenberg R (1991) Immunological and molecular characterization of plasminogen activator inhibitor 1 and 2 in baboon placental tissues. Biol Reprod, 45, 49-56.
13. Fawthrop RK & Ockleford CD (1994) Cryofracture of human term amniochorion. Cell Tissue Res, 277, 315-323.
14. Feinberg RF, Kliman HJ, Lockwood CJ & Charles J (1991) Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol, 138, 537-543.
15. Feng Q, Liu K, Hu ZY, Zou RJ, Yang SC & Liu YX (1993) Studies on the role of plasminogen activator in luteolysis of rhesus monkey. Hum Reprod, 8, 1640-1644.
16. Fisher SJ, Leitch MS, Kantor MS, Basbaum CB & Kramer RH (1985) Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas. J Cell Biochem, 27, 31-41.
17. Fisher SJ, Cui T-Y, Zhang L, Hartman L, Grahl K, Guo-Yang Z, Tarpey J & Damsky CH (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol, 109, 891-902.
18. Fox H (1978) Macroscopic abnormalities of the placenta In Pathology of the Placenta (Ed.) Fox H, pp. 95-148. London: W.B. Saunders.
19. Frank H-G, Malekzadeh F, Kertschauska S, Crescimanno C, Castellucci M, Lang I, Desoye G & Kaufmann P (1994) Immunohistochemistry of two different types of placental fibrinoid. Acta Anatomica, 150, 55-68.
20. Gilabert J, Estellés A, Ayuso MJ, España F, Chirivella M, Grancha S, Micó JM & Aznar J (1994) Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation. Gynecol Obstet Invest, 38, 157-162.
21. Graham CH (1997). Effect of transforming growth factor-β on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta, 18, 137-143.
22. Hofmann GE, Glatstein I, Schatz F, Heller D & Deligdisch L (1994) Immunohistochemical localization of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 and 2 in early human implantation sites. Am J Obstet Gynecol, 170, 671-676.
23. Hoyes AD (1970) Ultrastructure of the mesenchymal layers of the human amnion in early pregnancy. Am J Obstet Gynecol, 106, 557-566.
24. Hu ZY, Liu YX & Ockleford CD (1997) Confocal and conventional immunofluorescence localization of plasminogen activator and plasminogen activator inhibitors in human fetal membranes. Reprod Contracep, 17, 245-246.
25. Irving JA & Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration; regulation by TGF-β, IGF-II and IGFBP-1. Exp Cell Res, 217, 419-427.
26. Jonasson A, Larsson B, Lecander I & Åstedt B (1989) Placental and decidual uPA, tPA, PAI-1 and PAI-2 concentrations, as affected by cervical dilatation with laminaria tents or Hegar dilators. Thromb Res, 53, 91-97.
27. Kanayama N, Terao T, Kawashima Y, Horiuchi K & Funkimoto D (1985) Collagen types in normal and prematurely ruptured amniotic membranes. Am J Obstet Gynecol, 153, 899-903.
28. Kawano T, Morimoto K & Uemura Y (1968) Urokinase inhibitor in human placenta. Nature, 217, 253-256.
29. Klimaa G & Schmidt W (1988) Immunohistochemical studies of the nature of connective tissue in fetal membranes. Acta Histochem, 84, 195-203.
30. Kruithof EKO, Baker MS & Buhm CL (1995) Biological and clinical aspects of plasminogen activator inhibitor type-2. Blood, 86, 4007-4024.
31. Kruithof EKO, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, Welti H & Bachmann F (1987) Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors. Blood, 69, 460-466.
32. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH & Fisher SJ (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol, 113, 437-449.
33. Liu K, Brändström A, Liu YX, Ny T & Selstam G (1996) Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat. Endocrinology, 137, 2126-2132.
34. Liu YX, Peng XR & Ny T (1991) Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in rat ovary during gonadotropin-induced ovulation. Eur J Biochem, 195, 549-555.
35. Liu YX, Feng Q, Peng XR & Ny T (1994) Secretion of plasminogen activator inhibitor type-1 by cultured ovarian cells obtained from gonadotropin-treated immature rats. Sci China, 37, 940-947.
36. Liu YX, Cajander SB, Ny T, Kristensen P & Hsueh AJW (1987) Gonadotropin regulation of tissue-type and urokinase-type plasminogen activators in rat granulosa and theca-interstitial cells during the periovulatory period. Mol Cell Endocrinol, 54, 221-229.
37. Liu YX, Liu K, Zhou HM, Du Q, Hu ZY & Zou RJ (1995a) Hormonal regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I in cultured monkey Sertoli cells. Hum Reprod, 10, 719-727.
38. Liu YX, Chen YX, Shi FW & Feng Q (1995b) Studies on the role of plasminogen activators and plasminogen activator inhibitor type-I in rat corpus luteum of pregnancy. Biol Reprod, 53, 1131-1138.
39. Liu YX, Liu K, Du Q, Zhou HM, Hu ZY, Zhang GY & Zhang GH (1996) Preliminary studies on the role of plasminogen activator in seminal plasma of human and rhesus monkey. Mol Hum Reprod, 2, 99-104.
40. Liu YX, Hu ZY, Zou RJ & Ockleford CD (1997) Identification of secretion sites of tissue plasminogen activator and plasminogen activator inhibitor type-1 in basal plates of human and rhesus monkey placentae. Chin Sci Bull, 42, 1030-1033.
41. Mackay AR, Corbitt RH, Hartzler JL & Thorgeisson UP (1990) Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res, 50 5997-6001.
42. Martin O & Arias F (1982) Plasminogen activator production by trophoblast cells in vitro: Effect of steroid hormones and protein synthesis inhibitors. Am J Obstet Gynecol, 142, 402-409.
43. Matrisian LM (1992) The matrix degrading metalloproteinases. Bioessays, 14, 455-463.
44. McGregor JA, French JI, Lawellin D, Franco-Buff A, Smith C & Todd J (1987) Bacterial protease-induced reduction of chorioamniotic membranes' strength and elasticity. Obstet Gynecol, 69, 167-174.
45. Modesti A, Scarpa S, D'Orazi G, Simonelli L & Caraminia FG (1989) Developments in ultrastructure of reproduction. In Progress in Clinical and Biological Research, VIIIth International Symposium on Morphological Sciences (Ed.) Motta PM, pp. 459-464. New York: Allan R. Liss.
46. Monzón-Bordonaba F, Wang C-L & Feinberg RF (1997) Fibronectinase activity in cultured human trophoblasts is mediated by urokinase type plasminogen activator. Am J Obstet Gynaecol, 176, 58-65.
47. Nanaev AK, Rukosuev VS, Shirinsky VP, Milovanov AP, Domogatsky SP, Duance VC, Bradbury FM, Yarrow P, Gardiner L, d'Lacey C & Ockleford CD (1991) Confocal and conventional immunofluorescent and immunogold electron microscopic localization of collagen types III and IV in human placenta. Placenta, 12, 573-595.
48. Nilsson IM, Felding P, Lecander I, Lenner C & Åstedt B (1986) Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women. Br J Haematol, 62, 215.
49. Nitabuch R (1887) Beiträge zur Kenntniss der menschlichen Placenta. Doctoral thesis, University of Bern Stämpfli'sche Buchdruckerei, Switzerland.
50. Ny T, Sawdey M, Lawrence DA, Milan JL & Loskutoff DJ (1986) Cloning and sequence of a cDNA coding for the human β-migrating endothelial cell-type plasminogen activator inhibitor. Proc Nat Acad Sci USA. 83, 6776-6780.
51. Ny T, Hansson L, Lawrence D, Leonardsson G & Åstedt B (1989) Plasminogen activator inhibitor type-2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted. Fibrinolysis, 3, 189-196.
52. Ockleford CD, Bright NA, Hubbard A, d'Lacey C, Smith J, Gardiner L, Sheikh T, Albentosa M & Turtle K (1993a) Microtrabeculae, macro-plaques or mini-basement membranes in human term fetal membranes? Philos Trans R Soc London B, 342, 121-136.
53. Ockleford CD, Malak T, Hubbard ARD, Bracken K, Burton S, Bright NA, Blakey G, Goodliffe J, Garrod D & d'Lacey C (1993b) Confocal and conventional immunofluorescence and ultrastructural localisation of intercellular strength giving components of human amniochorion. J Anat, 183, 483-505.
54. Ockleford CD, McCracken SA, Rimmington LA, Hubbard ARD, Bright NA, Jefferson TB & d'Lacey C (1994) Type IV collagen may integrate amnion layers by association with type VII collagen rivets. J Anat, 184, 191.
55. Pennica D, Holmers WE & Kohr WJ (1982) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature, 301, 214-221.
56. Phillips M, Juul AG, Thorsen S, Selmer J & Zeuthen J (1986) Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood, platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta. Thromb Haemost, 55, 213-217.
57. Reith A, Booth NA, Moore NR, Cruickshank DJ & Bennett B (1993) Plasminogen activator inhibitor (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Gynaecol, 100, 370-379.
58. Rohr K (1889) Die Bezhiehungen der mütterlichen Gefässe zu den intervillössen Räumen der reifen Placenta speziel zur Thrombose derselben ("weisser infarct"). Virchows Arch Pathol Anat, 115, 505-534.
59. Sage H (1982) Collagens of basement membrane. J Invest Dermatol, 79, S51-S59.
60. Saksela O (1985) Plasminogen activation and the regulation of pericellular proteolysis. Biochim Biophys Acta, 823, 35-65.
61. Schaeren-Wiemers N & Gerfin-Moser A (1993) A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hydridization using digoxigenin-labelled cRNA probes. Histochemistry, 100, 431-440.
62. Schoonmaker JN, James JF & Lunt BD (1991) Protease and antiprotease activity in bacterially mediated rupture of fetal membranes. In The Extracellular Matrix of the Uterus Cervix and Fetal Membranes (Ed.) Lepport PC & Woessner JF, pp. 263-273. New York: Ithaca New York Perinatology Press.
63. Skinner SJM, Campos GA & Liggins GC (1981) Collagen content of human amniotic membranes: Effects of gestational length and premature rupture. Obstet Gynecol, 57, 487-489.
64. Smith J & Ockleford CD (1994) Laser scanning confocal examination and comparison of nidogen (entactin) with laminin in term human amniochorion. Placenta, 15, 95-106.
65. Toppozada MK, Sallam NA, Gaafarr AA & El-Kashlan KM (1970) Role of repeated stretching in the mechanism of timely rupture of the membranes. Am J Obstet Gynecol, 108, 243.
66. Uszynski M, Uszynski W & Kielkowski A (1995) Tissue plasminogen activator and plasminogen activator inhibitors of type-1 and 2 in amniotic fluid before labour and after childbirth. Gynecol Obstet Invest, 39, 93-96.
67. Verde P, Stoppelli MP & Galeffi PD (1984) Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc Nat Acad Sci USA, 81, 4727-4731.
68. Wun T-C & Reich E (1987) An inhibitor of plasminogen activation from human placenta. J Biol Chem, 262, 3646-3653.
69. Yagel S, Parhar RS, Jeffrey JJ & Lala PK (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol, 136, 455-462.
70. Ye RD, Wun T-C & Sadler JE (1987) cDNA cloning and expression in E.coli of a plasminogen activator inhibitor from human placenta. J Biol Chem, 262, 3718-3725.
71. Zhang T, Zhou HM & Liu YX (1997) Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes. Mol Hum Reprod, 3, 223-231.